167
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Modelling the complete continuum of care using system dynamics: the case of osteoarthritis in Alberta

, , &
Pages 156-169 | Received 31 Oct 2014, Accepted 17 Dec 2014, Published online: 19 Dec 2017

References

  • Australian Orthopaedic Association (2011). 2010 National Joint Registry Annual Report. Australian Orthopaedic Association: Adelaide.
  • BayerSPetsoulasCCoxBHoneymanABarlowJFacilitating stroke care planning through simulation modellingHealth Informatics Journal201016212914310.1177/1460458209361142
  • BessetteLRisebroughNMittmannNRoussyJPHoJZlatevaGCost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspectiveJournal of Medical Economics200912324625810.3111/13696990903288970
  • BombardierCHawkerGMosherDThe Impact of Arthritis in Canada: Today and over the Next 30 Years2011
  • Brailsford S and Hilton N (2001). A comparison of discrete event simulation and system dynamics for modelling health-care systems. In: Riley J (ed). Proceedings of the 26th Meeting of the ORAHS Working Group 2000. Glasgow Caledonian University: Glasgow, pp 18–39.
  • BrennanAChickSEDaviesRA taxonomy of model structures for economic evaluation of health technologiesHealth Economics200615121295131010.1002/hec.1148
  • CardosoTOliveiraMDBarbosa-PóvoaANickelSModeling the demand for long-term care services under uncertain informationHealth Care Management Science201215438541210.1007/s10729-012-9204-0
  • ChancellorJVHunscheEde CruzESarasinFPEconomic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in SwitzerlandPharmacoeconomics200119S1597510.2165/00019053-200119001-00005
  • DaviesRDaviesTUsing simulation to plan health service resources: Discussion paperJournal of the Royal Society of Medicine1986793154157
  • ElliottRAHooperLPayneKBrownTJRobertsCSymmonsDPreventing non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: Are older strategies more cost-effective in the general population?Rheumatology200645560661310.1093/rheumatology/kei241
  • Government of Alberta; Finance and Enterprise (2010). Alberta Population Projections by Census Division, 2010–2050. Government of Alberta: Edmonton.
  • HahlJA simulation model for estimating direct costs of type 1 diabetes preventionPharmacoeconomics200321529530310.2165/00019053-200321050-00001
  • HomerJHirschGMilsteinBChronic illness in a complex health economy: the perils and promises of downstream and upstream reformsSystem Dynamics Review2007232/331334310.1002/sdr.379
  • Institute of Medicine (2001). Crossing the Quality Chasm: A New Health System for the 21st Century. National Academy Press: Washington DC.
  • KamathCCKremersHMVannessDJO’FallonWMCabanelaRLGabrielSEThe cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritisValue in Health20036214415710.1046/j.1524-4733.2003.00215.x
  • KopecJADevelopment of a population-based microsimulation model of osteoarthritis in CanadaOsteoarthritis and Cartilage201018330331110.1016/j.joca.2009.10.010
  • KorostishevskyMWilliamsFHartDBlumenfeldOSpectorTLivshitsGImplementation of the simplified stochastic model of ageing for longitudinal osteoarthritis data assessmentAnnals of Human Biology201239321422210.3109/03014460.2012.681801
  • LagacéCPerrucioADeganoCNicholMWhat is arthritis and how common is it?Life with Arthritis in Canada: A Personal and Public Health Challenge20111631
  • LatimerNLordJGrantRLO’MahonyRDicksonJConaghanPGCost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritisBritish Medical Journal200933913 Julyb253810.1136/bmj.b2538
  • LatimerNLordJGrantRLO’MahonyRDicksonJConaghanPGValue of information in the osteoarthritis setting: Cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitorsPharmacoeconomics201129322523710.2165/11584200-000000000-00000
  • LawrenceRCEstimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis and Rheumatism2008581263510.1002/art.23176
  • LingSMTransitions to mobility difficulty associated with lower extremity osteoarthritis in high functioning older women: Longitudinal data from the women’s health and aging study IIArthritis and Rheumatism200655225626310.1002/art.21858
  • LosinaECost-effectiveness of total knee arthroplasty in the United States: Patient risk and hospital volumeArchives of Internal Medicine2009169121113112110.1001/archinternmed.2009.136
  • LosinaEImpact of obesity and knee osteoarthritis on morbidity and mortality in older AmericansAnnals of Internal Medicine2011154421722610.7326/0003-4819-154-4-201102150-00001
  • MaetzelAKrahnMNaglieGThe cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritisArthritis and Rheumatism200349328329210.1002/art.11121
  • MariottoABYabroffKRShaoYFeuerEJBrownMLProjections of the cost of cancer care in the United States: 2010–2020Journal of the National Cancer Institute2011103211710.1093/jnci/djq495
  • MarshallDAEstimating incidence and prevalence of osteoarthritis (OA) in Alberta using administrative claims dataOsteoarthritis and Cartilage201321supplementS16410.1016/j.joca.2013.02.351
  • National Physician Survey (2010). 2010 National Results by Province/Territory. National Physician Survey: Mississauga.
  • PliskinJSTellEJA dialysis need-forecasting model: A retrospective evaluationMedical Decision Making19833448950010.1177/0272989X8300300408
  • PostmaJMHospital care for persons with AIDS in the European UnionHealth Policy199741215717610.1016/S0168-8510(97)00019-5
  • SinghGMillerJDHuseDMPettittDD’AgostinoRBRussellMWConsequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritisJournal of Rheumatology2003304714719
  • SpiegelBMTargownikLDulaiGSGralnekIMThe cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritisAnnals of Internal Medicine20031381079580610.7326/0003-4819-138-10-200305200-00007
  • Statistics Canada (2010). Population projections for Canada, Provinces and Territories 2009–2036. Statistics Canada: Ottawa.
  • WagnerEHAustinBVonKorffMOrganizing care for patients with chronic illnessThe Millbank Quarterly199674451154410.2307/3350391
  • WeinsteinAMEstimating the burden of total knee replacement in the United StatesJournal of Bone and Joint Surgery, American Volume201395538539210.2106/JBJS.L.00206
  • WorniMSystem dynamics to model the unintended consequences of denying payment for venous thromboembolism after total knee arthroplastyPLoS ONE201274e3057810.1371/journal.pone.0030578
  • XuMGarbuzDSKuramotoLSobolevBClassifying health-related quality of life outcomes of total hip arthroplastyBMC Musculoskeletal Disorders20056September4810.1186/1471-2474-6-48

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.